Annual ROE
-562.35%
-311.79%-124.44%
31 December 2023
Summary:
Kala Pharmaceuticals annual return on equity is currently -562.35%, with the most recent change of -311.79% (-124.44%) on 31 December 2023. During the last 3 years, it has fallen by -401.46% (-249.52%). KALA annual ROE is now -1588.09% below its all-time high of 37.79%, reached on 31 December 2016.KALA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-448.61%
-52.58%-13.28%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly return on equity is currently -448.61%, with the most recent change of -52.58% (-13.28%) on 30 September 2024. Over the past year, it has dropped by -187.67% (-71.92%). KALA quarterly ROE is now -147.12% below its all-time high of 952.04%, reached on 31 December 2022.KALA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -124.4% | -71.9% |
3 y3 years | -249.5% | -228.3% |
5 y5 years | -720.1% | -234.9% |
KALA ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -249.5% | at low | -147.1% | +57.8% |
5 y | 5 years | -720.1% | at low | -147.1% | +57.8% |
alltime | all time | -1588.1% | +87.2% | -147.1% | +57.8% |
Kala Pharmaceuticals ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -448.61%(+13.3%) |
June 2024 | - | -396.03%(+7.3%) |
Mar 2024 | - | -368.95%(+30.4%) |
Dec 2023 | -562.35%(+124.4%) | -282.84%(+8.4%) |
Sept 2023 | - | -260.94%(+345.3%) |
June 2023 | - | -58.60%(-94.5%) |
Mar 2023 | - | -1062.69%(-211.6%) |
Dec 2022 | -250.56%(+2.6%) | 952.04%(-196.9%) |
Sept 2022 | - | -982.86%(+80.7%) |
June 2022 | - | -543.92%(+100.2%) |
Mar 2022 | - | -271.73%(+41.9%) |
Dec 2021 | -244.19%(+51.8%) | -191.50%(+40.1%) |
Sept 2021 | - | -136.66%(+14.8%) |
June 2021 | - | -119.06%(+23.8%) |
Mar 2021 | - | -96.19%(-6.7%) |
Dec 2020 | -160.89% | -103.06%(-2.7%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | -105.93%(-5.3%) |
June 2020 | - | -111.81%(-12.0%) |
Mar 2020 | - | -127.08%(-13.5%) |
Dec 2019 | -140.12%(+104.3%) | -146.89%(+9.7%) |
Sept 2019 | - | -133.95%(+12.8%) |
June 2019 | - | -118.72%(+14.0%) |
Mar 2019 | - | -104.17%(+20.3%) |
Dec 2018 | -68.57%(-98.4%) | -86.60%(+20.1%) |
Sept 2018 | - | -72.10%(+28.2%) |
June 2018 | - | -56.26%(-48.1%) |
Mar 2018 | - | -108.43%(-33.5%) |
Dec 2017 | -4403.86%(<-9900.0%) | -162.99%(-176.5%) |
Sept 2017 | - | 212.94%(+215.9%) |
June 2017 | - | 67.41%(-41.6%) |
Mar 2017 | - | 115.40%(+205.4%) |
Dec 2016 | 37.79%(+28.4%) | 37.79% |
Dec 2015 | 29.44% | - |
FAQ
- What is Kala Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual ROE year-on-year change?
- What is Kala Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly ROE year-on-year change?
What is Kala Pharmaceuticals annual return on equity?
The current annual ROE of KALA is -562.35%
What is the all time high annual ROE for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual return on equity is 37.79%
What is Kala Pharmaceuticals annual ROE year-on-year change?
Over the past year, KALA annual return on equity has changed by -311.79% (-124.44%)
What is Kala Pharmaceuticals quarterly return on equity?
The current quarterly ROE of KALA is -448.61%
What is the all time high quarterly ROE for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly return on equity is 952.04%
What is Kala Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, KALA quarterly return on equity has changed by -187.67% (-71.92%)